DALLAS - Computer systems and software developer IBM debuted a new financing package for medical equipment leasing yesterday at the Healthcare Information and Management Systems Society (HIMSS) conference.
The financial product, Progress Payment Offering for Medical Equipment Leasing, is a new program that facilitates advance, or progress, payments to medical equipment manufacturers while equipment is being built and installed, the Armonk, NY-based vendor said.
The company developed the option to service the financing needs of medical equipment customers from product ordering to final installation. The Progress Payment and Fair Market Value Lease financial products permit equipment customers to convert up-front capital investments into monthly payments without out-of-pocket expense prior to final installation, the company said.
The company's global financing division will create interest-only loans for customers for the amount that it advances to manufacturers. When the installation of the equipment is complete, the progress payment offering automatically converts to a fair market value lease, according to IBM.
By AuntMinnie.com staff writersFebruary 16, 2005
Related Reading
Road to RSNA, IBM, November 16, 2004
IBM, Siemens sign partnership deal, net installs, July 29, 2004
Emageon, IBM partner on financing, May 19, 2004
Cedara partners with IBM China, November 25, 2003
Road to RSNA, IBM, November 12, 2003
Copyright © 2005 AuntMinnie.com














![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&fit=crop&h=112&q=70&w=112)




